Biotech Values

[DewDiligence]

Thanks, Regulardoc. NVS may have made a decision not to compete for the VA business, which (along with so-called 340B institutions) is the least profitable part of the hospital universe for drug companies.

--
Do you have rough numbers on the proportion of hospital usage of each the seven Lovenox doses that come in a prefilled syringe? T.i.a. Dew